The agency publishes draft reference material for implementation of FDA’s quality metrics guidance.
On June 24, 2016, FDA released the draft Quality Metrics Technical Conformance Guide, which supplements FDA’s draft guidance, Request for Quality Metrics. The guide discusses the submission of quality metric data. Specifically, the guide addresses the format of electronic submissions, data element specifications, mandatory data elements, and optional data elements.
The guide also details data validation rules. Data validation is defined in the guide as “a process that attempts to ensure that submitted data are both compliant and useful.” FDA states in the guide that “data validation is one method used to assess submission data quality ⦠The data validation process can identify data issues early in the review that may adversely affect the use of the data.” FDA states that companies should validate their metric data before submission using the validation rules, which will be posted on the FDA website once the quality metrics guidance is finalized, and correct any validation errors.
Source: FDA
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
AES Clean Technology Launches Next-Generation OSM Utility Solution for Cleanrooms at INTERPHEX 2025
April 2nd 2025Officially launched at INTERPHEX 2025, the Omni ASCENT is a next-generation off-site manufactured vertical utility solution that offers optimized cleanroom flexibility and efficiency.